Rank | Gene Set | Z-score |
---|---|---|
1 | lysine metabolic process (GO:0006553) | 4.13831340 |
2 | lysine catabolic process (GO:0006554) | 4.13831340 |
3 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.07560765 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.04283124 |
5 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.97738450 |
6 | tricarboxylic acid cycle (GO:0006099) | 3.82330103 |
7 | carnitine shuttle (GO:0006853) | 3.81048676 |
8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.71633588 |
9 | synaptic vesicle maturation (GO:0016188) | 3.58044314 |
10 | fatty acid transmembrane transport (GO:1902001) | 3.57992338 |
11 | cell communication by electrical coupling (GO:0010644) | 3.55915491 |
12 | cell communication involved in cardiac conduction (GO:0086065) | 3.52638488 |
13 | aspartate family amino acid catabolic process (GO:0009068) | 3.52239658 |
14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.47659395 |
15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.44164837 |
16 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.43941198 |
17 | locomotory exploration behavior (GO:0035641) | 3.39867786 |
18 | ethanol oxidation (GO:0006069) | 3.39532214 |
19 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36944392 |
20 | regulation of membrane repolarization (GO:0060306) | 3.32234034 |
21 | short-chain fatty acid metabolic process (GO:0046459) | 3.29869093 |
22 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29840381 |
23 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.28654265 |
24 | cardiac muscle contraction (GO:0060048) | 3.26106432 |
25 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.25021971 |
26 | cardiac myofibril assembly (GO:0055003) | 3.22115510 |
27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.21683554 |
28 | regulation of sequestering of triglyceride (GO:0010889) | 3.21658151 |
29 | sodium ion export (GO:0071436) | 3.20064838 |
30 | vitamin transmembrane transport (GO:0035461) | 3.19272577 |
31 | fatty acid beta-oxidation (GO:0006635) | 3.18875656 |
32 | potassium ion import (GO:0010107) | 3.18583438 |
33 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.16289242 |
34 | ethanol metabolic process (GO:0006067) | 3.15201033 |
35 | carnitine transport (GO:0015879) | 3.12268690 |
36 | amino-acid betaine transport (GO:0015838) | 3.12268690 |
37 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.10831594 |
38 | plasma membrane repair (GO:0001778) | 3.10346117 |
39 | cellular ketone body metabolic process (GO:0046950) | 3.10230401 |
40 | regulation of fatty acid oxidation (GO:0046320) | 3.09379321 |
41 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.06217441 |
42 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.05544822 |
43 | NADH metabolic process (GO:0006734) | 3.05318010 |
44 | sarcomere organization (GO:0045214) | 3.04535385 |
45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.01591583 |
46 | regulation of actin filament-based movement (GO:1903115) | 3.00970581 |
47 | regulation of early endosome to late endosome transport (GO:2000641) | 3.00662574 |
48 | activation of protein kinase A activity (GO:0034199) | 3.00239429 |
49 | mannose metabolic process (GO:0006013) | 2.99777156 |
50 | carnitine transmembrane transport (GO:1902603) | 2.99752492 |
51 | succinate metabolic process (GO:0006105) | 2.98567843 |
52 | positive regulation of synapse maturation (GO:0090129) | 2.96831023 |
53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.94736319 |
54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93492339 |
55 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.91143304 |
56 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.89119717 |
57 | creatine metabolic process (GO:0006600) | 2.88992293 |
58 | * respiratory electron transport chain (GO:0022904) | 2.87860818 |
59 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.87528928 |
60 | cellular potassium ion homeostasis (GO:0030007) | 2.87300648 |
61 | cardiac conduction (GO:0061337) | 2.86147631 |
62 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.85844608 |
63 | positive regulation of fatty acid oxidation (GO:0046321) | 2.85237088 |
64 | membrane repolarization during action potential (GO:0086011) | 2.84194338 |
65 | regulation of cell communication by electrical coupling (GO:0010649) | 2.83765796 |
66 | relaxation of cardiac muscle (GO:0055119) | 2.83303413 |
67 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83283086 |
68 | cerebellar granule cell differentiation (GO:0021707) | 2.82652656 |
69 | membrane repolarization (GO:0086009) | 2.82158511 |
70 | tricarboxylic acid metabolic process (GO:0072350) | 2.82138091 |
71 | regulation of extracellular matrix disassembly (GO:0010715) | 2.81424031 |
72 | regulation of ARF protein signal transduction (GO:0032012) | 2.81281945 |
73 | regulation of coenzyme metabolic process (GO:0051196) | 2.80992658 |
74 | regulation of cofactor metabolic process (GO:0051193) | 2.80992658 |
75 | fatty acid oxidation (GO:0019395) | 2.80382036 |
76 | myofibril assembly (GO:0030239) | 2.79314643 |
77 | cellular sodium ion homeostasis (GO:0006883) | 2.78400677 |
78 | * electron transport chain (GO:0022900) | 2.78063873 |
79 | positive regulation of extracellular matrix organization (GO:1903055) | 2.77822619 |
80 | quaternary ammonium group transport (GO:0015697) | 2.77501437 |
81 | potassium ion homeostasis (GO:0055075) | 2.77020998 |
82 | lipid oxidation (GO:0034440) | 2.76901316 |
83 | glycine transport (GO:0015816) | 2.76672409 |
84 | regulation of synapse structural plasticity (GO:0051823) | 2.76629635 |
85 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.76528178 |
86 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.76522121 |
87 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.75990509 |
88 | fatty acid catabolic process (GO:0009062) | 2.73683591 |
89 | motile cilium assembly (GO:0044458) | 2.73488609 |
90 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.73102432 |
91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.72840915 |
92 | vocalization behavior (GO:0071625) | 2.72663067 |
93 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.72271293 |
94 | desmosome organization (GO:0002934) | 2.67344137 |
95 | phosphate ion transport (GO:0006817) | 2.65691187 |
96 | drug catabolic process (GO:0042737) | 2.64485308 |
97 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.63030427 |
98 | regulation of extracellular matrix organization (GO:1903053) | 2.62817094 |
99 | ketone body metabolic process (GO:1902224) | 2.62403518 |
100 | glutamate metabolic process (GO:0006536) | 2.62139713 |
101 | acetyl-CoA metabolic process (GO:0006084) | 2.61063566 |
102 | carnitine metabolic process (GO:0009437) | 2.60810674 |
103 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.60005321 |
104 | phosphate ion transmembrane transport (GO:0035435) | 2.59538573 |
105 | regulation of response to osmotic stress (GO:0047484) | 2.59525847 |
106 | dicarboxylic acid catabolic process (GO:0043649) | 2.58021479 |
107 | primary alcohol catabolic process (GO:0034310) | 2.57969275 |
108 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.57095099 |
109 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.56096842 |
110 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.56096842 |
111 | amino-acid betaine metabolic process (GO:0006577) | 2.55471879 |
112 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.55116178 |
113 | axonemal dynein complex assembly (GO:0070286) | 2.53672534 |
114 | protein retention in ER lumen (GO:0006621) | 2.53617303 |
115 | sodium ion homeostasis (GO:0055078) | 2.52619662 |
116 | monocarboxylic acid catabolic process (GO:0072329) | 2.51730194 |
117 | striated muscle contraction (GO:0006941) | 2.51213639 |
118 | cell volume homeostasis (GO:0006884) | 2.49378389 |
119 | exogenous drug catabolic process (GO:0042738) | 2.49170967 |
120 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.48790601 |
121 | glutamate secretion (GO:0014047) | 2.48619955 |
122 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.48603776 |
123 | cardiac muscle cell action potential (GO:0086001) | 2.48177720 |
124 | drug transmembrane transport (GO:0006855) | 2.47752107 |
125 | positive regulation of potassium ion transport (GO:0043268) | 2.46251153 |
126 | L-phenylalanine metabolic process (GO:0006558) | 2.44875903 |
127 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.44875903 |
128 | glyoxylate metabolic process (GO:0046487) | 2.44587644 |
129 | regulation of cholesterol homeostasis (GO:2000188) | 2.43595538 |
130 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43440960 |
131 | one-carbon compound transport (GO:0019755) | 2.42704205 |
132 | cell-cell junction maintenance (GO:0045217) | 2.41829260 |
133 | L-amino acid import (GO:0043092) | 2.39644521 |
134 | positive regulation of protein dephosphorylation (GO:0035307) | 2.39374136 |
135 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.38795789 |
136 | protein carboxylation (GO:0018214) | 2.38795789 |
137 | myelin maintenance (GO:0043217) | 2.38647570 |
138 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.35110626 |
139 | regulation of synapse maturation (GO:0090128) | 2.34306810 |
140 | amino acid import (GO:0043090) | 2.32662065 |
141 | central nervous system myelination (GO:0022010) | 2.32559130 |
142 | axon ensheathment in central nervous system (GO:0032291) | 2.32559130 |
143 | response to parathyroid hormone (GO:0071107) | 2.32070486 |
144 | synaptic vesicle exocytosis (GO:0016079) | 2.31534262 |
145 | regulation of apoptotic cell clearance (GO:2000425) | 2.30759804 |
146 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.29963239 |
147 | adhesion of symbiont to host (GO:0044406) | 2.29697764 |
148 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.29548061 |
149 | cellular response to reactive nitrogen species (GO:1902170) | 2.28263048 |
150 | dopamine receptor signaling pathway (GO:0007212) | 2.28159869 |
151 | adherens junction assembly (GO:0034333) | 2.23807040 |
152 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.20817100 |
153 | lung epithelium development (GO:0060428) | 2.20534653 |
154 | protein-lipid complex assembly (GO:0065005) | 2.19616632 |
155 | surfactant homeostasis (GO:0043129) | 2.19554807 |
156 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.18595437 |
157 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.18595437 |
158 | multicellular organismal water homeostasis (GO:0050891) | 2.17359258 |
159 | positive regulation of glucose import (GO:0046326) | 2.17121955 |
160 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.17108180 |
161 | regulation of cholesterol metabolic process (GO:0090181) | 2.16437402 |
162 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.15975005 |
163 | cellular response to nitric oxide (GO:0071732) | 2.15293161 |
164 | endothelial cell chemotaxis (GO:0035767) | 2.14955128 |
165 | focal adhesion assembly (GO:0048041) | 2.13486114 |
166 | cell-substrate adherens junction assembly (GO:0007045) | 2.13486114 |
167 | neuromuscular process controlling balance (GO:0050885) | 2.13137975 |
168 | positive regulation of steroid metabolic process (GO:0045940) | 2.11127172 |
169 | positive regulation of lipid catabolic process (GO:0050996) | 2.11009783 |
170 | cell junction maintenance (GO:0034331) | 2.10851230 |
171 | regulation of cholesterol esterification (GO:0010872) | 2.10473910 |
172 | actin filament depolymerization (GO:0030042) | 2.10321238 |
173 | positive regulation of glucose transport (GO:0010828) | 2.08234194 |
174 | regulation of protein dephosphorylation (GO:0035304) | 2.07196153 |
175 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.06711908 |
176 | regulation of protein activation cascade (GO:2000257) | 2.06614051 |
177 | regulation of complement activation (GO:0030449) | 2.06487401 |
178 | positive regulation of Rap GTPase activity (GO:0032854) | 2.04437028 |
179 | diacylglycerol metabolic process (GO:0046339) | 2.04197929 |
180 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.02674486 |
181 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.02653567 |
182 | regulation of ARF GTPase activity (GO:0032312) | 2.02539031 |
183 | adhesion of symbiont to host cell (GO:0044650) | 2.02478749 |
184 | virion attachment to host cell (GO:0019062) | 2.02478749 |
185 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.01604905 |
186 | activation of MAPKKK activity (GO:0000185) | 2.01180943 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.17075864 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.32760712 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16917566 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56423421 |
5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.55258254 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19499898 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18705579 |
8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16321872 |
9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10366205 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03637206 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02540206 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96975731 |
13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.92180395 |
14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.92180395 |
15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88911952 |
16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.87692596 |
17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87004714 |
18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84791193 |
19 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.77152316 |
20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76491562 |
21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75682732 |
22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73344197 |
23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72953426 |
24 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.72716797 |
25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.71994838 |
26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69727682 |
27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65177133 |
28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64291258 |
29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63542643 |
30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63188995 |
31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62940021 |
32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58921823 |
33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56025598 |
34 | P68_20966046_ChIP-Seq_HELA_Human | 1.54792486 |
35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53337514 |
36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52803457 |
37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51925776 |
38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49573310 |
39 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47096016 |
40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47096016 |
41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46972192 |
42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46827141 |
43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45090322 |
44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43976521 |
45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42089058 |
46 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.38800654 |
47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38307894 |
48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36518336 |
49 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35366593 |
50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34233618 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34075707 |
52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31084304 |
53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29046523 |
54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28968330 |
55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28381307 |
56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27825455 |
57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.27230228 |
58 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26617827 |
59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26071876 |
60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25547553 |
61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24950610 |
62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24120965 |
63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23992597 |
64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23000950 |
65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22689803 |
66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21883744 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20688223 |
68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20685840 |
69 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20507638 |
70 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.20496948 |
71 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18488577 |
72 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18016674 |
73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17898278 |
74 | MYC_22102868_ChIP-Seq_BL_Human | 1.17400846 |
75 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.16688992 |
76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16442842 |
77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16194919 |
78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15570303 |
79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14890312 |
80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13043325 |
81 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10133573 |
82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09844497 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09815326 |
84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09434909 |
85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09256602 |
86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08880088 |
87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08756829 |
88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06659845 |
89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06018033 |
90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05982764 |
91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05127369 |
92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04489909 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04470047 |
94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.04117450 |
95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03401197 |
96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02938940 |
97 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01991369 |
98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01073759 |
99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01021776 |
100 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00904834 |
101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00587313 |
102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99939101 |
103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99295744 |
104 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98307046 |
105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98287488 |
106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98109456 |
107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97794304 |
108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96705591 |
109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96310301 |
110 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96226695 |
111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95751410 |
112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94967418 |
113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93773197 |
114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91308827 |
115 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90784255 |
116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90454504 |
117 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90148551 |
118 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89717026 |
119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89559522 |
120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88885931 |
121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87813329 |
122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87274758 |
123 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85990299 |
124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85777166 |
125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85538498 |
126 | AR_19668381_ChIP-Seq_PC3_Human | 0.83864793 |
127 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.81591388 |
128 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80621710 |
129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79315707 |
130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78315825 |
131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78315825 |
132 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.78184392 |
133 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.77686581 |
134 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77624183 |
135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77051559 |
136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76259025 |
137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76152788 |
138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75641833 |
139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75610681 |
140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75598715 |
141 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75323637 |
142 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74693138 |
143 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74660713 |
144 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73446070 |
145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73277275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 3.68640915 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 3.36264426 |
3 | MP0004859_abnormal_synaptic_plasticity | 3.35281018 |
4 | MP0005409_darkened_coat_color | 3.26805164 |
5 | MP0000751_myopathy | 3.25181426 |
6 | MP0005360_urolithiasis | 3.02371730 |
7 | MP0004130_abnormal_muscle_cell | 2.92974520 |
8 | MP0002822_catalepsy | 2.80078112 |
9 | MP0004084_abnormal_cardiac_muscle | 2.77526013 |
10 | MP0004215_abnormal_myocardial_fiber | 2.77152825 |
11 | MP0005058_abnormal_lysosome_morphology | 2.71587742 |
12 | MP0002139_abnormal_hepatobiliary_system | 2.67669993 |
13 | MP0005085_abnormal_gallbladder_physiolo | 2.51470411 |
14 | MP0005330_cardiomyopathy | 2.38021104 |
15 | MP0004036_abnormal_muscle_relaxation | 2.31918989 |
16 | MP0000678_abnormal_parathyroid_gland | 2.28425964 |
17 | MP0003172_abnormal_lysosome_physiology | 2.24795649 |
18 | MP0003195_calcinosis | 2.19038169 |
19 | MP0005666_abnormal_adipose_tissue | 2.07535806 |
20 | MP0009840_abnormal_foam_cell | 2.06229345 |
21 | * MP0004043_abnormal_pH_regulation | 2.05400050 |
22 | MP0004185_abnormal_adipocyte_glucose | 2.04661669 |
23 | MP0004484_altered_response_of | 2.03256786 |
24 | MP0008961_abnormal_basal_metabolism | 1.94793283 |
25 | MP0004087_abnormal_muscle_fiber | 1.94104342 |
26 | MP0009780_abnormal_chondrocyte_physiolo | 1.94099095 |
27 | MP0002909_abnormal_adrenal_gland | 1.91919404 |
28 | MP0004145_abnormal_muscle_electrophysio | 1.86590858 |
29 | MP0000749_muscle_degeneration | 1.86012745 |
30 | MP0008775_abnormal_heart_ventricle | 1.85209521 |
31 | MP0005332_abnormal_amino_acid | 1.84398070 |
32 | MP0002972_abnormal_cardiac_muscle | 1.79960654 |
33 | MP0005620_abnormal_muscle_contractility | 1.79859617 |
34 | MP0002089_abnormal_postnatal_growth/wei | 1.77159697 |
35 | MP0003635_abnormal_synaptic_transmissio | 1.76743181 |
36 | MP0005365_abnormal_bile_salt | 1.73281129 |
37 | MP0003137_abnormal_impulse_conducting | 1.72282810 |
38 | MP0003252_abnormal_bile_duct | 1.69984436 |
39 | MP0002249_abnormal_larynx_morphology | 1.69311844 |
40 | * MP0006036_abnormal_mitochondrial_physio | 1.60653904 |
41 | MP0002877_abnormal_melanocyte_morpholog | 1.54465785 |
42 | MP0000747_muscle_weakness | 1.53872062 |
43 | MP0005535_abnormal_body_temperature | 1.50900202 |
44 | MP0003123_paternal_imprinting | 1.50701653 |
45 | MP0001502_abnormal_circadian_rhythm | 1.48793837 |
46 | MP0004270_analgesia | 1.48652065 |
47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48179528 |
48 | MP0005375_adipose_tissue_phenotype | 1.46851773 |
49 | MP0005670_abnormal_white_adipose | 1.45364113 |
50 | MP0005385_cardiovascular_system_phenoty | 1.43642999 |
51 | MP0001544_abnormal_cardiovascular_syste | 1.43642999 |
52 | MP0005451_abnormal_body_composition | 1.41412260 |
53 | MP0002106_abnormal_muscle_physiology | 1.41138885 |
54 | MP0002971_abnormal_brown_adipose | 1.40340904 |
55 | MP0003183_abnormal_peptide_metabolism | 1.39776224 |
56 | MP0002796_impaired_skin_barrier | 1.39734380 |
57 | MP0004085_abnormal_heartbeat | 1.39546548 |
58 | MP0000750_abnormal_muscle_regeneration | 1.38577827 |
59 | MP0003453_abnormal_keratinocyte_physiol | 1.36537025 |
60 | MP0009745_abnormal_behavioral_response | 1.35868354 |
61 | MP0001765_abnormal_ion_homeostasis | 1.34344126 |
62 | MP0006138_congestive_heart_failure | 1.34021368 |
63 | MP0010329_abnormal_lipoprotein_level | 1.33263597 |
64 | MP0010630_abnormal_cardiac_muscle | 1.33228047 |
65 | MP0009115_abnormal_fat_cell | 1.30718429 |
66 | MP0005076_abnormal_cell_differentiation | 1.28559614 |
67 | MP0002118_abnormal_lipid_homeostasis | 1.26379159 |
68 | MP0002269_muscular_atrophy | 1.23086494 |
69 | MP0000604_amyloidosis | 1.21043992 |
70 | MP0005167_abnormal_blood-brain_barrier | 1.20022431 |
71 | MP0002063_abnormal_learning/memory/cond | 1.19809105 |
72 | MP0000013_abnormal_adipose_tissue | 1.19135561 |
73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18822305 |
74 | MP0010234_abnormal_vibrissa_follicle | 1.18007752 |
75 | MP0002876_abnormal_thyroid_physiology | 1.17146637 |
76 | MP0002064_seizures | 1.15986853 |
77 | MP0005369_muscle_phenotype | 1.15519984 |
78 | MP0000920_abnormal_myelination | 1.12202258 |
79 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11871764 |
80 | MP0000759_abnormal_skeletal_muscle | 1.11780435 |
81 | MP0009643_abnormal_urine_homeostasis | 1.11013940 |
82 | MP0009046_muscle_twitch | 1.10189774 |
83 | MP0002078_abnormal_glucose_homeostasis | 1.09909780 |
84 | MP0003868_abnormal_feces_composition | 1.08902058 |
85 | MP0003283_abnormal_digestive_organ | 1.07654424 |
86 | MP0004233_abnormal_muscle_weight | 1.07589345 |
87 | MP0005423_abnormal_somatic_nervous | 1.07359934 |
88 | MP0004510_myositis | 1.07237254 |
89 | MP0003879_abnormal_hair_cell | 1.06409278 |
90 | MP0008569_lethality_at_weaning | 1.05925879 |
91 | MP0001486_abnormal_startle_reflex | 1.05347951 |
92 | MP0003300_gastrointestinal_ulcer | 1.05013961 |
93 | MP0004019_abnormal_vitamin_homeostasis | 1.03436838 |
94 | MP0000230_abnormal_systemic_arterial | 1.02363970 |
95 | MP0002138_abnormal_hepatobiliary_system | 1.01944377 |
96 | MP0005166_decreased_susceptibility_to | 1.01744833 |
97 | MP0003634_abnormal_glial_cell | 1.00545337 |
98 | MP0004885_abnormal_endolymph | 0.99791342 |
99 | MP0004782_abnormal_surfactant_physiolog | 0.99624770 |
100 | MP0005503_abnormal_tendon_morphology | 0.98067361 |
101 | MP0000681_abnormal_thyroid_gland | 0.96437359 |
102 | MP0001849_ear_inflammation | 0.95083042 |
103 | MP0003880_abnormal_central_pattern | 0.94594767 |
104 | MP0001501_abnormal_sleep_pattern | 0.93691380 |
105 | MP0000003_abnormal_adipose_tissue | 0.93291638 |
106 | MP0003329_amyloid_beta_deposits | 0.92800845 |
107 | MP0003279_aneurysm | 0.89512083 |
108 | MP0003690_abnormal_glial_cell | 0.87973501 |
109 | MP0001756_abnormal_urination | 0.87906464 |
110 | MP0004264_abnormal_extraembryonic_tissu | 0.87209599 |
111 | MP0003705_abnormal_hypodermis_morpholog | 0.87138622 |
112 | MP0005319_abnormal_enzyme/_coenzyme | 0.86572534 |
113 | MP0001958_emphysema | 0.85897236 |
114 | MP0003828_pulmonary_edema | 0.85782689 |
115 | MP0002970_abnormal_white_adipose | 0.85587436 |
116 | MP0003075_altered_response_to | 0.85249468 |
117 | MP0001346_abnormal_lacrimal_gland | 0.85144232 |
118 | MP0005165_increased_susceptibility_to | 0.84842201 |
119 | MP0002896_abnormal_bone_mineralization | 0.84276396 |
120 | MP0003303_peritoneal_inflammation | 0.83972982 |
121 | MP0002272_abnormal_nervous_system | 0.83617679 |
122 | MP0003633_abnormal_nervous_system | 0.83516238 |
123 | MP0001440_abnormal_grooming_behavior | 0.83421049 |
124 | MP0005623_abnormal_meninges_morphology | 0.82293709 |
125 | MP0002734_abnormal_mechanical_nocicepti | 0.81900937 |
126 | MP0003045_fibrosis | 0.80837168 |
127 | MP0001666_abnormal_nutrient_absorption | 0.80552803 |
128 | MP0005083_abnormal_biliary_tract | 0.79330916 |
129 | MP0004858_abnormal_nervous_system | 0.79193850 |
130 | MP0001348_abnormal_lacrimal_gland | 0.78496063 |
131 | MP0005386_behavior/neurological_phenoty | 0.77508059 |
132 | MP0004924_abnormal_behavior | 0.77508059 |
133 | MP0008874_decreased_physiological_sensi | 0.77353004 |
134 | MP0005448_abnormal_energy_balance | 0.76471607 |
135 | MP0003878_abnormal_ear_physiology | 0.76198747 |
136 | MP0005377_hearing/vestibular/ear_phenot | 0.76198747 |
137 | MP0000566_synostosis | 0.73842495 |
138 | MP0002332_abnormal_exercise_endurance | 0.73680730 |
139 | MP0002572_abnormal_emotion/affect_behav | 0.73577107 |
140 | MP0005501_abnormal_skin_physiology | 0.73273099 |
141 | MP0009379_abnormal_foot_pigmentation | 0.72843140 |
142 | MP0005187_abnormal_penis_morphology | 0.72689310 |
143 | MP0005646_abnormal_pituitary_gland | 0.72641632 |
144 | MP0003566_abnormal_cell_adhesion | 0.71020064 |
145 | MP0002108_abnormal_muscle_morphology | 0.70442498 |
146 | MP0000733_abnormal_muscle_development | 0.68202073 |
147 | MP0001664_abnormal_digestion | 0.67743908 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Obstructive sleep apnea (HP:0002870) | 4.80691634 |
2 | Sudden death (HP:0001699) | 4.54831198 |
3 | Ventricular fibrillation (HP:0001663) | 4.39810927 |
4 | Exercise-induced myalgia (HP:0003738) | 4.10906589 |
5 | Bundle branch block (HP:0011710) | 4.08012024 |
6 | Myoglobinuria (HP:0002913) | 3.89167955 |
7 | Ketoacidosis (HP:0001993) | 3.66234427 |
8 | Exercise-induced muscle cramps (HP:0003710) | 3.64897527 |
9 | Hypoglycemic coma (HP:0001325) | 3.57357303 |
10 | Atrial fibrillation (HP:0005110) | 3.48332542 |
11 | Syncope (HP:0001279) | 3.37979574 |
12 | Gout (HP:0001997) | 3.36129685 |
13 | Hyperglycinuria (HP:0003108) | 3.34808243 |
14 | Primary atrial arrhythmia (HP:0001692) | 3.29368304 |
15 | Calf muscle hypertrophy (HP:0008981) | 3.27589387 |
16 | Ventricular tachycardia (HP:0004756) | 3.26126255 |
17 | Ketosis (HP:0001946) | 3.25713210 |
18 | Prolonged QT interval (HP:0001657) | 3.23829684 |
19 | Heart block (HP:0012722) | 3.16115103 |
20 | Myokymia (HP:0002411) | 3.10536344 |
21 | Complement deficiency (HP:0004431) | 3.08115755 |
22 | Neurofibrillary tangles (HP:0002185) | 3.07591619 |
23 | Supraventricular tachycardia (HP:0004755) | 3.06293283 |
24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.06218947 |
25 | Systemic lupus erythematosus (HP:0002725) | 3.04244479 |
26 | Ventricular arrhythmia (HP:0004308) | 3.01950173 |
27 | Right ventricular cardiomyopathy (HP:0011663) | 2.99893307 |
28 | Atrioventricular block (HP:0001678) | 2.99154830 |
29 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.99024433 |
30 | Supraventricular arrhythmia (HP:0005115) | 2.98961511 |
31 | Abnormal atrioventricular conduction (HP:0005150) | 2.98639494 |
32 | Abnormality of glycine metabolism (HP:0010895) | 2.95396774 |
33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95396774 |
34 | Muscle fiber splitting (HP:0003555) | 2.92287817 |
35 | Hyporeflexia of lower limbs (HP:0002600) | 2.81952148 |
36 | Nonprogressive disorder (HP:0003680) | 2.79648890 |
37 | Increased circulating renin level (HP:0000848) | 2.78644531 |
38 | Nasal polyposis (HP:0100582) | 2.78509182 |
39 | Hyperammonemia (HP:0001987) | 2.78324568 |
40 | Abnormality of the nasal mucosa (HP:0000433) | 2.77830250 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.75124976 |
42 | Abnormality of the calf musculature (HP:0001430) | 2.73112954 |
43 | Atelectasis (HP:0100750) | 2.69715432 |
44 | Asymmetric septal hypertrophy (HP:0001670) | 2.68891907 |
45 | Distal lower limb muscle weakness (HP:0009053) | 2.67739424 |
46 | Metabolic alkalosis (HP:0200114) | 2.65861377 |
47 | Abnormal EKG (HP:0003115) | 2.65818311 |
48 | Difficulty running (HP:0009046) | 2.64608587 |
49 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.63087761 |
50 | Absent/shortened dynein arms (HP:0200106) | 2.63087761 |
51 | Hyperglycinemia (HP:0002154) | 2.60259235 |
52 | Cerebral inclusion bodies (HP:0100314) | 2.58266495 |
53 | Abnormality of complement system (HP:0005339) | 2.57598308 |
54 | Focal motor seizures (HP:0011153) | 2.56920149 |
55 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.55870074 |
56 | Subaortic stenosis (HP:0001682) | 2.55870074 |
57 | Glomerulonephritis (HP:0000099) | 2.55337118 |
58 | Palpitations (HP:0001962) | 2.53931481 |
59 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.49834608 |
60 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.49834608 |
61 | Supranuclear gaze palsy (HP:0000605) | 2.48993044 |
62 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.48676242 |
63 | Hypokalemic alkalosis (HP:0001949) | 2.47359422 |
64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.47275832 |
65 | Dicarboxylic aciduria (HP:0003215) | 2.46207277 |
66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46207277 |
67 | Abnormal ciliary motility (HP:0012262) | 2.45260118 |
68 | Increased purine levels (HP:0004368) | 2.43922579 |
69 | Hyperuricemia (HP:0002149) | 2.43922579 |
70 | Hypercortisolism (HP:0001578) | 2.43540815 |
71 | Proximal tubulopathy (HP:0000114) | 2.40431552 |
72 | Hyperacusis (HP:0010780) | 2.35952800 |
73 | Hyperparathyroidism (HP:0000843) | 2.35599346 |
74 | Rhabdomyolysis (HP:0003201) | 2.32962497 |
75 | Hemorrhage of the eye (HP:0011885) | 2.32604306 |
76 | Lipoatrophy (HP:0100578) | 2.31270327 |
77 | Generalized aminoaciduria (HP:0002909) | 2.30165300 |
78 | Abnormality of chloride homeostasis (HP:0011422) | 2.30069210 |
79 | Visual hallucinations (HP:0002367) | 2.29473364 |
80 | Action tremor (HP:0002345) | 2.28843449 |
81 | Dysmetric saccades (HP:0000641) | 2.27299739 |
82 | Abnormality of binocular vision (HP:0011514) | 2.24698082 |
83 | Diplopia (HP:0000651) | 2.24698082 |
84 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.22228122 |
85 | Hyperactive renin-angiotensin system (HP:0000841) | 2.21044813 |
86 | Hyperthyroidism (HP:0000836) | 2.20977453 |
87 | Hyperphosphatemia (HP:0002905) | 2.19654864 |
88 | Xanthomatosis (HP:0000991) | 2.19498303 |
89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.17305817 |
90 | Truncus arteriosus (HP:0001660) | 2.16702411 |
91 | Delayed CNS myelination (HP:0002188) | 2.16561618 |
92 | EMG: myopathic abnormalities (HP:0003458) | 2.16467014 |
93 | Muscle stiffness (HP:0003552) | 2.15261474 |
94 | Protrusio acetabuli (HP:0003179) | 2.14123167 |
95 | Upper limb amyotrophy (HP:0009129) | 2.13909646 |
96 | Distal upper limb amyotrophy (HP:0007149) | 2.13909646 |
97 | Dilated cardiomyopathy (HP:0001644) | 2.13890082 |
98 | Impaired social interactions (HP:0000735) | 2.13449123 |
99 | Abnormal social behavior (HP:0012433) | 2.13449123 |
100 | Abnormality of purine metabolism (HP:0004352) | 2.12775093 |
101 | Papilledema (HP:0001085) | 2.10430206 |
102 | Chronic bronchitis (HP:0004469) | 2.09523826 |
103 | Ankle clonus (HP:0011448) | 2.08807554 |
104 | Abnormality of renin-angiotensin system (HP:0000847) | 2.06751523 |
105 | Myopathic facies (HP:0002058) | 2.05575133 |
106 | Male infertility (HP:0003251) | 2.04930284 |
107 | Metabolic acidosis (HP:0001942) | 2.04487279 |
108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04249203 |
109 | Anxiety (HP:0000739) | 2.03967924 |
110 | Rhinitis (HP:0012384) | 2.03635576 |
111 | Hyperaldosteronism (HP:0000859) | 2.03219540 |
112 | Axonal loss (HP:0003447) | 2.01322212 |
113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00871755 |
114 | Late onset (HP:0003584) | 2.00176104 |
115 | Myotonia (HP:0002486) | 2.00153370 |
116 | Adrenal overactivity (HP:0002717) | 1.99817757 |
117 | Hyperkalemia (HP:0002153) | 1.98875789 |
118 | Poor eye contact (HP:0000817) | 1.97890906 |
119 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.97889088 |
120 | Abnormality of the Achilles tendon (HP:0005109) | 1.97849260 |
121 | Dysdiadochokinesis (HP:0002075) | 1.97520425 |
122 | Foot dorsiflexor weakness (HP:0009027) | 1.97119563 |
123 | Cerebral aneurysm (HP:0004944) | 1.96533149 |
124 | Hypoalphalipoproteinemia (HP:0003233) | 1.95245941 |
125 | Flat acetabular roof (HP:0003180) | 1.93608538 |
126 | Increased connective tissue (HP:0009025) | 1.93534847 |
127 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93104215 |
128 | Polycythemia (HP:0001901) | 1.92763319 |
129 | Purpura (HP:0000979) | 1.91251661 |
130 | Hyperglycemia (HP:0003074) | 1.90768477 |
131 | Nausea (HP:0002018) | 1.89997890 |
132 | Malnutrition (HP:0004395) | 1.87619407 |
133 | Conjunctival hamartoma (HP:0100780) | 1.87255960 |
134 | Vascular calcification (HP:0004934) | 1.86979636 |
135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86199382 |
136 | Neonatal onset (HP:0003623) | 1.86152230 |
137 | Focal seizures (HP:0007359) | 1.85918877 |
138 | Bronchomalacia (HP:0002780) | 1.85042587 |
139 | Nuclear cataract (HP:0100018) | 1.83174174 |
140 | Neuronal loss in central nervous system (HP:0002529) | 1.82288004 |
141 | Status epilepticus (HP:0002133) | 1.81934378 |
142 | Depression (HP:0000716) | 1.81862692 |
143 | Bowel incontinence (HP:0002607) | 1.81713795 |
144 | Achilles tendon contracture (HP:0001771) | 1.81525741 |
145 | Abnormality of potassium homeostasis (HP:0011042) | 1.81140481 |
146 | Hepatic necrosis (HP:0002605) | 1.80964867 |
147 | Postural instability (HP:0002172) | 1.80812965 |
148 | Cerebral edema (HP:0002181) | 1.80000318 |
149 | Dysostosis multiplex (HP:0000943) | 1.79985989 |
150 | Deep venous thrombosis (HP:0002625) | 1.79470861 |
151 | Lymphangioma (HP:0100764) | 1.79382232 |
152 | Pheochromocytoma (HP:0002666) | 1.79372769 |
153 | Increased muscle lipid content (HP:0009058) | 1.79176955 |
154 | Sudden cardiac death (HP:0001645) | 1.78270427 |
155 | Abnormality of the foot musculature (HP:0001436) | 1.78008650 |
156 | Hypophosphatemia (HP:0002148) | 1.77077333 |
157 | Stridor (HP:0010307) | 1.75607668 |
158 | Bell-shaped thorax (HP:0001591) | 1.74375027 |
159 | Increased cerebral lipofuscin (HP:0011813) | 1.73398296 |
160 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71412368 |
161 | Abnormality of the thoracic spine (HP:0100711) | 1.70406551 |
162 | Insomnia (HP:0100785) | 1.69666145 |
163 | Recurrent otitis media (HP:0000403) | 1.69279497 |
164 | Sleep apnea (HP:0010535) | 1.68954647 |
165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68706830 |
166 | Mucopolysacchariduria (HP:0008155) | 1.68706830 |
167 | Pseudobulbar signs (HP:0002200) | 1.67827803 |
168 | Rigidity (HP:0002063) | 1.67116099 |
169 | Shallow orbits (HP:0000586) | 1.65500550 |
170 | Turricephaly (HP:0000262) | 1.64956363 |
171 | J-shaped sella turcica (HP:0002680) | 1.63674355 |
172 | Hypotension (HP:0002615) | 1.62558705 |
173 | EMG: neuropathic changes (HP:0003445) | 1.62550424 |
174 | Peripheral hypomyelination (HP:0007182) | 1.61917978 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.52946921 |
2 | CDK12 | 3.24692638 |
3 | LMTK2 | 3.01658999 |
4 | WNK4 | 2.78339283 |
5 | PRKD3 | 2.54588688 |
6 | PKN2 | 2.52589888 |
7 | PRPF4B | 2.49953472 |
8 | STK38 | 2.45922116 |
9 | ERN1 | 2.41955232 |
10 | EPHA4 | 2.32502895 |
11 | PDK3 | 2.30077285 |
12 | PDK4 | 2.30077285 |
13 | PHKG2 | 2.29148217 |
14 | PHKG1 | 2.29148217 |
15 | MAP3K9 | 2.19116188 |
16 | PINK1 | 2.17474017 |
17 | ICK | 2.13091014 |
18 | TTN | 2.06326381 |
19 | NEK1 | 2.06269786 |
20 | EEF2K | 1.97799535 |
21 | DMPK | 1.97306803 |
22 | DAPK2 | 1.96310706 |
23 | FGFR4 | 1.95428162 |
24 | NTRK3 | 1.94332650 |
25 | MAPK15 | 1.87188188 |
26 | BCKDK | 1.85732618 |
27 | KSR2 | 1.83382874 |
28 | RIPK1 | 1.78689656 |
29 | MAPKAPK3 | 1.77097261 |
30 | TAOK1 | 1.73018350 |
31 | CAMKK1 | 1.72660012 |
32 | PAK6 | 1.60756414 |
33 | MAP2K4 | 1.58088367 |
34 | SIK2 | 1.54389935 |
35 | MARK2 | 1.46422799 |
36 | WNK1 | 1.44819031 |
37 | STK39 | 1.41422623 |
38 | SMG1 | 1.39214031 |
39 | MINK1 | 1.34186452 |
40 | OXSR1 | 1.32356046 |
41 | PDK2 | 1.27360290 |
42 | MAP3K4 | 1.23422818 |
43 | PAK3 | 1.22359780 |
44 | ALK | 1.14257368 |
45 | MAP3K2 | 1.13067382 |
46 | FGFR3 | 1.12408946 |
47 | TESK1 | 1.12131332 |
48 | MAP3K7 | 1.10708435 |
49 | STK11 | 1.09023341 |
50 | OBSCN | 1.08743006 |
51 | TNK2 | 1.07006858 |
52 | PDPK1 | 1.06852660 |
53 | WNK3 | 1.05405013 |
54 | CAMK1 | 1.00927805 |
55 | PIK3CA | 0.99791563 |
56 | PRKCH | 0.99558118 |
57 | MTOR | 0.97847011 |
58 | EPHA2 | 0.97498299 |
59 | CDC42BPA | 0.96929689 |
60 | RET | 0.94832291 |
61 | MAP3K1 | 0.94711273 |
62 | HIPK2 | 0.94186386 |
63 | LATS2 | 0.93201440 |
64 | EPHB1 | 0.92136968 |
65 | PDK1 | 0.91637990 |
66 | CAMK1G | 0.89159812 |
67 | PTK2 | 0.87998981 |
68 | PRKD1 | 0.87058070 |
69 | NTRK1 | 0.84321739 |
70 | FER | 0.83968560 |
71 | CAMK2D | 0.78607179 |
72 | MAP3K3 | 0.78525264 |
73 | NEK9 | 0.78088431 |
74 | CAMK4 | 0.76444095 |
75 | PRKAA2 | 0.76105924 |
76 | STK24 | 0.76073642 |
77 | MARK1 | 0.75197531 |
78 | PDGFRA | 0.74966783 |
79 | SGK3 | 0.73272762 |
80 | INSRR | 0.72362329 |
81 | MST1R | 0.72006644 |
82 | CAMK1D | 0.71977350 |
83 | CDK5 | 0.71149077 |
84 | MYLK | 0.69340960 |
85 | MAPK11 | 0.68172543 |
86 | TIE1 | 0.67111090 |
87 | PRKAA1 | 0.67054023 |
88 | MAPK10 | 0.66876733 |
89 | PDGFRB | 0.66290370 |
90 | PRKD2 | 0.66158452 |
91 | ARAF | 0.65823306 |
92 | FES | 0.65108547 |
93 | CAMK2G | 0.64977748 |
94 | CAMK2A | 0.64642060 |
95 | MAP3K6 | 0.64594378 |
96 | MAP2K2 | 0.64474502 |
97 | SGK1 | 0.62607258 |
98 | RPS6KA2 | 0.61332355 |
99 | MAPK7 | 0.60631589 |
100 | FRK | 0.59873197 |
101 | SGK223 | 0.59575643 |
102 | SGK494 | 0.59575643 |
103 | STK38L | 0.58490272 |
104 | MAP3K10 | 0.58110097 |
105 | MAP3K13 | 0.56393665 |
106 | TYRO3 | 0.55796560 |
107 | MAP3K11 | 0.54831728 |
108 | BRD4 | 0.54673080 |
109 | CAMKK2 | 0.54125698 |
110 | TRPM7 | 0.53880217 |
111 | MUSK | 0.53418194 |
112 | DDR2 | 0.53035244 |
113 | RIPK4 | 0.52559702 |
114 | MAP2K7 | 0.52524676 |
115 | JAK2 | 0.52092879 |
116 | TAOK2 | 0.51423093 |
117 | PRKACG | 0.51106617 |
118 | RPS6KA3 | 0.49855581 |
119 | PTK6 | 0.49116172 |
120 | ZAP70 | 0.47956272 |
121 | BMX | 0.46606581 |
122 | UHMK1 | 0.46561643 |
123 | ROCK1 | 0.46245448 |
124 | PRKG2 | 0.44960079 |
125 | DAPK3 | 0.44713354 |
126 | ABL2 | 0.43367768 |
127 | NEK6 | 0.41573256 |
128 | CAMK2B | 0.41261916 |
129 | NTRK2 | 0.41188541 |
130 | TYK2 | 0.39869431 |
131 | JAK1 | 0.39473402 |
132 | TBK1 | 0.39386955 |
133 | MAP2K6 | 0.39128950 |
134 | PRKCG | 0.39022241 |
135 | MAPK4 | 0.38684734 |
136 | SGK2 | 0.38485373 |
137 | MAP3K5 | 0.36605451 |
138 | MAPK12 | 0.36517517 |
139 | PTK2B | 0.35645145 |
140 | MAP2K1 | 0.34702759 |
141 | SIK1 | 0.33971520 |
142 | PRKCZ | 0.33420039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32957851 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.12419892 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71296920 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.67603565 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51784648 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.46709168 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32238664 |
8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22361525 |
9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21134390 |
10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.05131471 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02240607 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88228737 |
13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.86699943 |
14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.79809969 |
15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78919443 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54770230 |
17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51002200 |
18 | Bile secretion_Homo sapiens_hsa04976 | 1.47860356 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46358313 |
20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43341367 |
21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.39341093 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37123480 |
23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36496419 |
24 | Prion diseases_Homo sapiens_hsa05020 | 1.36042320 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35665488 |
26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.30664915 |
27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.29100519 |
28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29040665 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27083830 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23468031 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23376307 |
32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18473564 |
33 | Insulin secretion_Homo sapiens_hsa04911 | 1.18311251 |
34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15269013 |
35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14888342 |
36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11971105 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11400711 |
38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10467456 |
39 | GABAergic synapse_Homo sapiens_hsa04727 | 1.04332636 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01167965 |
41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00771404 |
42 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99867846 |
43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97892469 |
44 | Salivary secretion_Homo sapiens_hsa04970 | 0.97861668 |
45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.97755238 |
46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96517521 |
47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96292681 |
48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95327389 |
49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93912096 |
50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.93570350 |
51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92911109 |
52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90527342 |
53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89541244 |
54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89198067 |
55 | Peroxisome_Homo sapiens_hsa04146 | 0.88205926 |
56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86584428 |
57 | Morphine addiction_Homo sapiens_hsa05032 | 0.86571235 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86067479 |
59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85260736 |
60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84420132 |
61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83520733 |
62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83349405 |
63 | Insulin resistance_Homo sapiens_hsa04931 | 0.82080769 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.81809419 |
65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81736806 |
66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81693084 |
67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80682194 |
68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80665810 |
69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80582087 |
70 | Renin secretion_Homo sapiens_hsa04924 | 0.80143818 |
71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79756427 |
72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78870087 |
73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78262637 |
74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77323845 |
75 | Mineral absorption_Homo sapiens_hsa04978 | 0.76277828 |
76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75961843 |
77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75520249 |
78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74855160 |
79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74780844 |
80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73906839 |
81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71588038 |
82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71512059 |
83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71209243 |
84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70388917 |
85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70051848 |
86 | Amoebiasis_Homo sapiens_hsa05146 | 0.70028064 |
87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68844407 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68819656 |
89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68550882 |
90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68472755 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68409742 |
92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67546061 |
93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66376693 |
94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66333284 |
95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66144325 |
96 | Lysosome_Homo sapiens_hsa04142 | 0.66057552 |
97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65562123 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63861084 |
99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63468294 |
100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62692205 |
101 | Tight junction_Homo sapiens_hsa04530 | 0.62645591 |
102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62604451 |
103 | ABC transporters_Homo sapiens_hsa02010 | 0.62106592 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61649221 |
105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60487085 |
106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59001615 |
107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58810920 |
108 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58480321 |
109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58037047 |
110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57749649 |
111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56951257 |
112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56333960 |
113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56178188 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56093600 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55742399 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55031974 |
117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54864665 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54648660 |
119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54403420 |
120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53294060 |
121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52130287 |
122 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51202347 |
123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50644165 |
124 | Glioma_Homo sapiens_hsa05214 | 0.49640005 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.49063899 |
126 | Taste transduction_Homo sapiens_hsa04742 | 0.47071429 |
127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46903214 |
128 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46450703 |
129 | Gap junction_Homo sapiens_hsa04540 | 0.44730085 |
130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43103876 |
131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40821099 |
132 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40517650 |
133 | Long-term depression_Homo sapiens_hsa04730 | 0.38675686 |
134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38044728 |
135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37149069 |
136 | Melanogenesis_Homo sapiens_hsa04916 | 0.34928311 |
137 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34489434 |
138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31686362 |
139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30537934 |
140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29934293 |